FDA approves twice-yearly HIV prevention shot amid questions over cost, access By Garrett Hottle June 20, 2025 5:39 PM Published June 20, 2025 5:34 PM ...

The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo. Phase 3 trials showed that 99.9% of those using the injections remained HIV-negative at a two-year follow-up.

If you're still scratching your head about what to get your dad or for yourself for Father's Day, then we have the deal for you. During the Father's Day Sale from now through June 17, an MLB.TV Yearly ...

NHPR talked with several graduating seniors what they imagine life after high school will look like. Aidan Tanguay, 18, of Auburn, will keep the full-time welding job he has now thanks to the ...